These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15991239)

  • 41. Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data.
    Eaton AA; Sima CS; Panageas KS
    J Natl Compr Canc Netw; 2016 Jan; 14(1):57-65. PubMed ID: 26733555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers.
    Silva AAD; Carlotto J; Rotta I
    Einstein (Sao Paulo); 2018 Jun; 16(2):eRW4074. PubMed ID: 29898094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews.
    Du XL; Key CR; Dickie L; Darling R; Geraci JM; Zhang D
    Med Care; 2006 Feb; 44(2):124-31. PubMed ID: 16434911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical Exercise and Cancer: Exploring Chemotherapy Infusion as an Opportunity for Movement.
    Miller R; Northey J; Toohey K
    Semin Oncol Nurs; 2020 Oct; 36(5):151068. PubMed ID: 33008684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
    Crivellari D; Colleoni M; Dellapasqua S; Goldhirsch A
    Tumori; 2009; 95(1):130; author reply 131. PubMed ID: 19366074
    [No Abstract]   [Full Text] [Related]  

  • 46. Aminoglycoside administration in paediatrics: a literature search comparing international practices of intravenous injection or intravenous infusion.
    Manning A; Burgess A
    Arch Dis Child Educ Pract Ed; 2024 Aug; ():. PubMed ID: 38594064
    [No Abstract]   [Full Text] [Related]  

  • 47. [Toxicological aspects of antineoplastic chemotherapy with vincaleukoblastine: rapid intermittent intravenous therapy].
    Periti P; Gerli P; Cattaneo A
    Riv Ostet Ginecol; 1969 Oct; 24(10):293-310. PubMed ID: 5401184
    [No Abstract]   [Full Text] [Related]  

  • 48. A technique to prevent overfilling of viewing chamber of intravenous infusion kit.
    Kakani L; Sharma SM; Mehta RC; Singh G
    Indian J Anaesth; 2014; 58(6):780-1. PubMed ID: 25624558
    [No Abstract]   [Full Text] [Related]  

  • 49. Modes of Administering Oxygen.
    Richardson BW
    Hospital (Lond 1886); 1894 Jan; 15(380):211-212. PubMed ID: 29831154
    [No Abstract]   [Full Text] [Related]  

  • 50. Simplifying infusion chemotherapy.
    Goodyear M; Levine M
    J R Soc Med; 1989 Mar; 82(3):184. PubMed ID: 20894727
    [No Abstract]   [Full Text] [Related]  

  • 51. New Modes of Administering Iodine.
    Buffalo Med J Mon Rev Med Surg Sci; 1859 Feb; 14(9):561. PubMed ID: 35376561
    [No Abstract]   [Full Text] [Related]  

  • 52. Modes in Which Drugs Have Been Introduced to Use.
    Dilling WJ
    Br Med J; 1927 Sep; 2(3481):546-8. PubMed ID: 20773417
    [No Abstract]   [Full Text] [Related]  

  • 53. Hospitalization rates from radiotherapy complications in the United States.
    Tonse R; Ramamoorthy V; Rubens M; Saxena A; McGranaghan P; Veledar E; Hall MD; Chuong MD; Ahluwalia MS; Mehta MP; Kotecha R
    Sci Rep; 2022 Mar; 12(1):4371. PubMed ID: 35288636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospitalization rates for complications due to systemic therapy in the United States.
    Saxena A; Rubens M; Ramamoorthy V; Tonse R; Veledar E; McGranaghan P; Sundil S; Chuong MD; Hall MD; Odia Y; Mehta MP; Kotecha R
    Sci Rep; 2021 Apr; 11(1):7385. PubMed ID: 33795827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional Nanosized Drug Delivery Systems for Cancer Applications.
    Vergallo C; Hafeez MN; Iannotta D; Santos HA; D'Avanzo N; Dini L; Cilurzo F; Fresta M; Di Marzio L; Christian C
    Adv Exp Med Biol; 2021; 1295():3-27. PubMed ID: 33543453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer: insights in disease and influence of drug methotrexate.
    Yang V; Gouveia MJ; Santos J; Koksch B; Amorim I; Gärtner F; Vale N
    RSC Med Chem; 2020 Jun; 11(6):646-664. PubMed ID: 33479665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.
    Chen Y; Lairson DR; Chan W; Du XL
    Med Oncol; 2017 Sep; 34(9):153. PubMed ID: 28776319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Provider Differences in Use of Implanted Ports in Older Adults With Cancer.
    Lipitz-Snyderman A; Elkin EB; Atoria CL; Sima CS; Epstein AS; Blinder V; Sepkowitz KA; Bach PB
    Med Care; 2015 Jul; 53(7):646-52. PubMed ID: 26035043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).
    Lamont EB; Yu M; He Y; Saltz L; Muss H; Zaslavsky AM;
    J Geriatr Oncol; 2014 Jul; 5(3):230-7. PubMed ID: 24594119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.
    Delate T; Bowles EJ; Pardee R; Wellman RD; Habel LA; Yood MU; Nekhlyudov L; Goddard KA; Davis RL; McCarty CA; Onitilo AA; Feigelson HS; Freml J; Wagner E
    Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):673-80. PubMed ID: 22337532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.